- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Genprex (NASDAQ:GNPX), Quotes and News Summary
Genprex (NASDAQ: GNPX)
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-14 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-30 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Genprex Questions & Answers
You can purchase shares of Genprex (NASDAQ: GNPX) through any online brokerage.
Other companies in Genprex’s space includes: Alzamend Neuro (NASDAQ:ALZN), CytomX Therapeutics (NASDAQ:CTMX), OncoCyte (NASDAQ:OCX), Ambrx Biopharma (NYSE:AMAM) and Gelesis Holdings (NYSE:GLS).
The latest price target for Genprex (NASDAQ: GNPX) was reported by Maxim Group on Friday, September 14, 2018. The analyst firm set a price target for 5.00 expecting GNPX to rise to within 12 months (a possible 106.61% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Genprex (NASDAQ: GNPX) is $2.42 last updated August 17, 2022, 8:00 PM UTC.
There are no upcoming dividends for Genprex.
Genprex’s Q3 earnings are confirmed for Monday, November 14, 2022.
There is no upcoming split for Genprex.
Genprex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.